The clinical efficacy of a continuous psoas compartment - sciatic nerve block in patients undergoing a total hip arthroplasty.

The clinical efficacy of a continuous psoas compartment - sciatic nerve block in patients undergoing a total hip arthroplasty. - CPCSNB and clinical efficacy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35115

Enrollment

Registered

2010-08-20

Start date

2010-04-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total hip arthroplasty and peripheral nerve block

Interventions

Psoas Compartment - Sciatic nerve block.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients undergoing total hip arthroplasty under spinal anesthesia ASA I-II (American Society of Anesthesiologists class I-II) age > 18 years

Exclusion criteria

Exclusion criteria: contra indications for peripheral nerve blocks (coagulopathies, infection at puncture site, allergy for local anesthetics). allergy to contrast agents. patients not being able to proper communication (dementia)

Design outcomes

Primary

Measure	Time frame
Pain scores (Numeric Rating Scale, whereby 0= no pain and 10=worst pain imaginable.	—

Secondary

Measure	Time frame
Sensory block (numer of dermatomes with a loss of cold sensation tested by application of a ice-cube). Motor block: Bromage Scale (0=no block, 3 = total block). Opioids consumption via teh Patient Controlled Analgesia pump. (mg morphine/day) Patient satisfaction: Numerieke Rating Scale of satisfaction.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)